HemoGenyx Pharmaceuticals Plc (HOPHF)
2.33
0.00 (0.00%)
USD |
OTCM |
Oct 13, 16:00
HemoGenyx Pharmaceuticals Free Cash Flow : -1.937M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.937M |
| December 31, 2025 | -4.274M |
| June 30, 2025 | -6.943M |
| December 31, 2024 | -5.331M |
| June 30, 2024 | -6.452M |
| December 31, 2023 | -7.624M |
| June 30, 2023 | -6.922M |
| December 31, 2022 | -4.013M |
| Date | Value |
|---|---|
| June 30, 2022 | -4.374M |
| December 31, 2021 | -4.699M |
| June 30, 2021 | -3.388M |
| December 31, 2020 | -2.826M |
| June 30, 2020 | -1.641M |
| December 31, 2019 | -1.531M |
| June 30, 2019 | -1.803M |
| December 31, 2018 | -1.830M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Silence Therapeutics Plc | -41.79M |
| Biodexa Pharmaceuticals Plc | -10.63M |
| NuCana Plc | -6.612M |
| Mereo BioPharma Group Plc | -25.58M |
| Compass Pathways Plc | -160.76M |
Free Cash Flow Related Metrics
| Free Cash Flow Yield | -13.32% |